Could broccoli compound slow Parkinson's and MS? new trial launches

NCT ID NCT07360977

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a supplement made from a broccoli compound (bioactivated GRA) in 300 people with Parkinson's disease, relapsing-remitting multiple sclerosis, or certain childhood nerve diseases. Participants will take the supplement daily for 6 months. Researchers will track changes in movement, thinking, brain scans, and quality of life to see if the compound can protect nerves and slow disease progression.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
bioactivated glucoraphanin (GRA) from broccoli
What this could lead to
If it works, this could point toward a simple dietary supplement that helps slow nerve damage and improve quality of life in Parkinson's, multiple sclerosis, and similar conditions.
What could go wrong
This is an early-stage trial with no placebo group, so results may be due to natural variation. The supplement is not a cure, and benefits may be small or absent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS (MS) RELAPSING REMITTING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • IRCCS Centro Neurolesi Bonino Pulejo

    RECRUITING

    Messina, 98124, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.